Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

NCT03175835 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: Rosuvastatin 20 mg
DRUG: CKD-519 200 mg
DRUG: Rosuvastatin 20 mg & CKD-519 200 mg

Sponsor

Chong Kun Dang Pharmaceutical